Company profile
Royalty Pharma plc insider acquisitions
Company CIK 0001802768 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
7 dated transactions · 6 of 6 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Dec 31, 2025 | Royalty Pharma plcClass A Ordinary Shares | Bassler Bonnie L | Stock award |
| Nov 7, 2025 | Royalty Pharma plcClass A Ordinary Shares | Urist Marshall | Conversion |
| Nov 5, 2025 | Royalty Pharma plcClass A Ordinary Shares | Urist Marshall | Stock award |
| Nov 5, 2025 | Royalty Pharma plcClass A Ordinary Shares | Lloyd George W. | Stock award |
| Nov 5, 2025 | Royalty Pharma plcClass A Ordinary Shares | Coyne Terrance P. | Stock award |
| Nov 5, 2025 | Royalty Pharma plcClass A Ordinary Shares | Hite Christopher | Stock award |
| Nov 5, 2025 | Royalty Pharma plcClass A Ordinary Shares | Legorreta Pablo G. | Stock award |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
RPRX · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Bassler Bonnie LDirector | Stock awardClass A Ordinary SharesNon-derivative security · Code A | 967 | 38.7418 *Value: 37,463.3206Currency not specified | View ↗ |
| Trade: | Urist MarshallEVP, Research & Investments | ConversionClass A Ordinary SharesNon-derivative security · Code C | 160,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Urist MarshallEVP, Research & Investments | Stock awardClass A Ordinary SharesNon-derivative security · Code A | 4,626 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Lloyd George W.EVP, Investments & CLO | Stock awardClass A Ordinary SharesNon-derivative security · Code A | 6,168 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Coyne Terrance P.EVP & CFO | Stock awardClass A Ordinary SharesNon-derivative security · Code A | 6,168 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Hite ChristopherEVP & Vice Chairman | Stock awardClass A Ordinary SharesNon-derivative security · Code A | 6,168 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Legorreta Pablo G.CEO, Chairman of the Board · Director | Stock awardClass A Ordinary SharesNon-derivative security · Code A | 36,559 | 0Value: 0Currency not specified | View ↗ |
7 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →